Skip to main content
OpenTrials

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

112 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

NCT06308978

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Autoimmune Diseases, +28 more
Locations
  • Wallace Rheumatic Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • University of California Irvine Irvine, California, United States
  • Children's Hospital Los Angeles Division Of Rheumatology Los Angeles, California, United States
View all 21 locations
View Trial Details
Recruiting

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

NCT06868290

Conditions
ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +18 more
Locations
  • University Of Colorado Aurora, Colorado, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 35 locations
View Trial Details

Related conditions